New Issue: Orbital Catastrophe Ahead? Read Now

Bacteria Might Share the Blame for Eczema

In patients with severe eczema, Staphylococcus aureus strains dominated the skin microbe population—suggesting that certain types of bacteria could worsen eczema flares. Christopher Intagliata reports. 

Illustration of a Bohr atom model spinning around the words Science Quickly with various science and medicine related icons around the text

Join Our Community of Science Lovers!

Your skin—like many other parts of your body—is crawling with microscopic critters. "It's a microbial zoo in a sense." Heidi Kong, a dermatology researcher at the National Institutes of Health.

That microbial zoo—and the types of microbes in it—changes over time. Kong and her team observed those changes during a flare-up of eczema—a condition characterized by itchy, inflamed skin. On healthy skin, and on patients with mild eczema, the researchers found a diverse roster of bacterial residents—including a species of Staph bacteria called Staphylococcus epidermidis. But in patients suffering a severe bout of eczema, that diversity was disrupted. And strains of a different Staph species dominated: Staphylococcus aureus.

The research team then collected Staph aureus strains from the eczema sufferers and swabbed them on the skin of mice. And that once-healthy mouse skin grew thicker—as it does in eczema—and was invaded by immune-response cells. While not proof, the result suggests that certain strains of Staph bacteria could be culpable in worsening eczema flares. The study is in the journal Science Translational Medicine. [Allyson L. Byrd et al., Staphylococcus aureus and Staphylococcus epidermidis strain diversity underlying pediatric atopic dermatitis]


On supporting science journalism

If you're enjoying this article, consider supporting our award-winning journalism by subscribing. By purchasing a subscription you are helping to ensure the future of impactful stories about the discoveries and ideas shaping our world today.


The genetic technique Kong and her team used—called shotgun metagenomics—gives a detailed snapshot of the microbiome. So it might be used to investigate other skin conditions too. 

"For example, acne has been linked with Propionibacterium acne. There's interest in looking at other inflammatory skin diseases, such as rosacea or even psoriasis. So there is the potential to use shotgun metagenomics to study inflammatory skin diseases and even skin cancers, to better understand: what are the microbes that might be there, and what they may be doing." 

And whether certain members of that microbial menagerie might be mistreating the zookeeper.

—Christopher Intagliata

[The above text is a transcript of this podcast.]

Subscribe to Support Independent Journalism

Great science journalism requires human expertise, time, effort and creativity. And it costs money. That’s why I and the journalists here at Scientific American hope you’ll join our community.

When you subscribe, you are supporting staff and freelance journalists who are passionate about telling science stories that are true, important and compelling. Our editors and reporters are often experts in their fields, which means they understand the nuances of big discoveries and can untangle the breakthroughs from the hype. With a subscription, you are also supporting rigorous fact-checking to ensure the words we publish are precise and accurate. And you’re supporting original illustrations, graphics and photos that bring you closer to an advanced laboratory, an ice sheet in Antarctica or a space mission in orbit. You’re helping us craft other types of high-quality journalism as well: Our newsletters are carefully written, edited and curated by staffers you have or will come to know and love. Our Science Quickly podcast is based on original reporting, collaboration with editors and scientists and exacting production.

Subscriptions keep this engine running so we can continue to deliver thoughtful, rigorous and independent science journalism to you. In an era of viral misinformation, this work is crucial. If you value what we do, I hope you’ll consider joining us as a subscriber

Thank you,

Jeanna Bryner, Editor in Chief, Scientific American

Subscribe